Gainers: •$Antares Pharma(ATRS.US)$+48.7% (to be acquired by Halozyme (HALO) for $5.60 per share) •$Sierra Oncology(SRRA.US)$+37.9% (acquired by GSK for $55 per share) •$Amryt Pharma(AMYT.US)$+11.7% (announces positive long-term safety and efficacy data for Mycapssa (oral octreotide) from the 2nd Year of OPTIMAL open label extension study in acromegaly patients) •$ブライアセル・セラピューティクス(BCTX.US)$+6% (presents development details of...
オシスコ・ゴールド・ロイヤルティーズに関するコメント
コラムToday's pre-market stock movers: AMC, GRAB, ZM, CS and more
• $CatchMark Timber Trust Inc(CTT.US)$ +36.4% (CatchMark Timber Trust and PotlatchDeltic (PCH) to combine in an all-stock transaction)
• $Yamana Gold(AUY.US)$ +17.0% (Yamana Gold to be acquired by Gold Fields (GFI) for $6.7 bln)
• $AMCエンターテインメント クラスA(AMC.US)$ +12.7% (strong "Top Gun: Maverick" box office showing)
• $KEホールディングス(BEKE.US)$ +8.3% (In reaction to earnings)
• $エレドン・ファーマシューティカルズ(ELDN.US)$ +7.7% (topline resul...
コラムToday's pre-market stock movers: DAL, JPM, NSTG, ATRS and more
•$Antares Pharma(ATRS.US)$ +48.7% (to be acquired by Halozyme (HALO) for $5.60 per share)
•$Sierra Oncology(SRRA.US)$ +37.9% (acquired by GSK for $55 per share)
•$Amryt Pharma(AMYT.US)$ +11.7% (announces positive long-term safety and efficacy data for Mycapssa (oral octreotide) from the 2nd Year of OPTIMAL open label extension study in acromegaly patients)
•$ブライアセル・セラピューティクス(BCTX.US)$ +6% (presents development details of...
コラムToday's pre-market stock movers: STNE, ONON, USAS and more
In reaction to earnings/guidance:
• $ストーン(STNE.US)$ +28.4% (also announces executive hires), $オン・ホールディング(ONON.US)$ +8.27%, $アメリカズ・シルバー(USAS.US)$ +3.85%, $トーリッド・ホールディングス(CURV.US)$ +0.8%
Other news:
• $レキシコン・ファーマシューティカルズ(LXRX.US)$ +4.5% (enters into loan facility to support commercialization of sotagliflozin)
• $TMCザ・メタルズ(TMC.US)$ +3.2% (signs term sheet for development of commercial system to collect deep-sea pol...
まだコメントはありません